Get started
HCMED INNOVATIONS CO LTDHCMED INNOVATIONS CO LTDHCMED INNOVATIONS CO LTD

HCMED INNOVATIONS CO LTD

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

6934 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

HCmed Innovations Co Ltd. provides platforms for inhalation therapy using mesh technology. Its products include Pulmogine and AdheResp. The firm offers comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. It also offers analytical support in compliance with Pharmacopoeia guidelines. The company was founded by Jason Cheng, Leon Tsai, Shaogi Huang and Simon Hsieh on October 06, 2014 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6934 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company